“Thanks to dozens of quick-acting universities and institutions in Australia, Europe & North America, a new effort to secure Open Science infrastructure is off to a strong start. More than 680 000 Euros have been pledged to support DOAJ and SHERPA/RoMEO already.”
“Stephen Buranyi’s piece from last summer “Is the staggeringly profitable business of scientific publishing bad for science?” (short answer: yes) and Jon Tennant’s “Scholarly publishing is broken. Here’s how to fix it” are timely reminders that the open access movement matters to us as a society, that it is a movement that involves fighting against forces with priorities very different from our own, and that–in addition to reminders about what’s at stake in this battle–we need practical, actionable advice to get us where we want to go.”
“We believe more discourse around research is a good thing. To that end, we have partnered with Hypothesis, a third-party platform, to allow for annotation and discussion on our preprints services. Annotation on preprints will increase transparency in scientific practices by enabling researchers to collaborate, discuss research with peers, and share additional information directly on preprints both before and after they are posted.”
“As organizations committed to the availability of information about our government and its transparency, we write to express our support for the Equal Access to Congressional Research Service Reports Act of 2016 (S. 2639), introduced last week. We extend our sincere gratitude for your many years of leadership in support of opening access to these valuable, taxpayer-funded reports. We are appreciative of your efforts, and those of Sen. Patrick Leahy, to make a bipartisan push for a more open government at a time when such work is particularly vital to our democracy.”
“OICR-funded drug discovery project’s unique ‘open science’ business model is accelerating the search for a solution to lethal pediatric brain cancers Diffuse intrinsic pontine glioma (DIPG) is a lethal and inoperable brain cancer with a median survival of less than a year from diagnosis. Finding solutions to this disease is challenging due to its rarity, scientific complexity and its presentation in pediatric populations. An OICR-funded team of researchers, led by Dr. Aled Edwards from M4K Pharma, have developed new potential drug candidates for DIPG that they will test in animal models in the coming months. They’ve reached this milestone ahead of schedule, with fewer resources required than anticipated, by using an ‘open drug discovery’ approach – sharing their methods and data with the greater research community to streamline the drug discovery process….”
“Open access is growing across the industry, but it can be hard to know which articles are open and which are subscription. Being able to easily find and identify open access content saves researchers time and effort. With Elsevier’s new partnership with Impactstory, a nonprofit that creates online tools to make science more open and reusable, researchers will soon be able to find open access content on Scopus more efficiently. Meanwhile, for university research offices, the expansion of OA-identified content in Scopus will enable improved strategic analysis and benchmarking.
“The open access movement has done a great job of making content open, but it hasn’t always made this open content easy to find,” said Jason Priem, co-founder of Impactstory. “By partnering with Elsevier, we’re are able to get that OA content out there where it can be used. We think this is a key step toward a more powerful, universally open science communication ecosystem.” The agreement will enable Elsevier to integrate document-level OA data from Impactstory’s Unpaywall database with Scopus content; identification and tagging of Scopus’ OA peer-reviewed articles will begin in August and roll out through November 2018….”
“Hindawi submitted a proposal this May in response to the European Commission’s tender to launch a new publishing platform. The Commission’s aim is to build on their progressive Open Science agenda to provide an optional Open Access publishing platform for the articles of all researchers with Horizon 2020 grants. The platform will also provide incentives for researchers to adopt Open Science practices, such as publishing preprints, sharing data, and open peer review. The potential for this initiative to lead a systemic transformation in research practice and scholarly communication in Europe and more widely should not be underestimated. Here we outline our bid to the Commission and our rationale for doing so.”
“Experts say the database of carefully curated medical guidelines is one of a kind, used constantly by medical professionals, and on July 16 will ‘go dark’ due to budget cuts.
The Trump Administration is planning to eliminate a vast trove of medical guidelines that for nearly 20 years has been a critical resource for doctors, researchers and others in the medical community. Maintained by the Agency for Healthcare Research and Quality [AHRQ], part of the Department of Health and Human Services, the database is known as the National Guideline Clearinghouse [NGC], and it’s scheduled to “go dark,” in the words of an official there, on July 16. Medical guidelines like those compiled by AHRQ aren’t something laypeople spend much time thinking about, but experts like Valerie King, a professor in the Department of Family Medicine and Director of Research at the Center for Evidence-based Policy at Oregon Health & Science University, said the NGC is perhaps the most important repository of evidence-based research available. “Guideline.gov was our go-to source, and there is nothing else like it in the world,” King said, referring to the URL at which the database is hosted, which the agency says receives about 200,000 visitors per month. “It is a singular resource,” King added. Medical guidelines are best thought of as cheatsheets for the medical field, compiling the latest research in an easy-to use format. When doctors want to know when they should start insulin treatments, or how best to manage an HIV patient in unstable housing — even something as mundane as when to start an older patient on a vitamin D supplement — they look for the relevant guidelines. The documents are published by a myriad of professional and other organizations, and NGC has long been considered among the most comprehensive and reliable repositories in the world. AHRQ said it’s looking for a partner that can carry on the work of NGC, but that effort hasn’t panned out yet. “AHRQ agrees that guidelines play an important role in clinical decision making, but hard decisions had to be made about how to use the resources at our disposal,” said AHRQ spokesperson Alison Hunt in an email. The operating budget for the NGC last year was $1.2 million, Hunt said, and reductions in funding forced the agency’s hand.”
“In 2005, [George Church] launched the Personal Genome Project (PGP), which collects data on a person’s DNA, environmental background, and relevant health and disease information from consenting participants. The premise of the PGP is grounded in open science, meaning that all this data is publicly available to researchers, who then study the relationship between specific DNA sequences and various displayed traits, like having an especially good memory.
This openness is the hallmark of the PGP, described on their website as “a vision and coalition of projects across the world dedicated to creating public genome, health, and trait data.” The PGP seeks to share data for the “greater good” in ways that have been previously “hampered by traditional research practices.” In other words, by being set up so it’s open-access project that allows individuals to freely share their data with researchers, no single researcher can “control” access to the data. By inviting participants to openly share their own personal data, this project allows individuals to directly impact scientific progress….”